Human Molecular Genetics, 2002, Vol. 11, No. 2 133-145
© 2002 Oxford University Press
High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer’s disease brain
Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10021, USA and 1Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
The mitochondrial theory of aging proposes that mitochondrial DNA (mtDNA) accumulates mutations with age, and that these mutations contribute to physiological decline in aging and degenerative diseases. Although a great deal of indirect evidence supports this hypothesis, the aggregate burden of mtDNA mutations, particularly point mutations, has not been systematically quantified in aging or neurodegenerative disorders. Therefore, we directly assessed the aggregate burden of brain mtDNA point mutations in 17 subjects with Alzheimer’s disease (AD), 10 elderly control subjects and 14 younger control subjects, using a PCR-cloning-sequencing strategy. We found that brain mtDNA from elderly subjects had a higher aggregate burden of mutations than brain mtDNA from younger subjects. The average aggregate mutational burden in elderly subjects was 2 x 10–4 mutations/bp. The bulk of these mutations were individually rare point mutations, 60% of which changed an amino acid. Control experiments ensure that these results were not due to artifacts arising from PCR error, mistaken identification of nuclear pseudogenes or ex vivo oxidation. Cytochrome oxidase activity correlated negatively with increasing mutational burden. These findings significantly bolster the mitochondrial theory of aging.
+ To whom correspondence should be addressed. Tel: +1 212 746 4573; Fax: +1 212 746 8276; Email: mtl2002@med.cornell.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Shokolenko, N. Venediktova, A. Bochkareva, G. L. Wilson, and M. F. Alexeyev Oxidative stress induces degradation of mitochondrial DNA Nucleic Acids Res., May 1, 2009; 37(8): 2539 - 2548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hayashi, M. Yoshida, M. Yamato, T. Ide, Z. Wu, M. Ochi-Shindou, T. Kanki, D. Kang, K. Sunagawa, H. Tsutsui, et al. Reverse of Age-Dependent Memory Impairment and Mitochondrial DNA Damage in Microglia by an Overexpression of Human Mitochondrial Transcription Factor A in Mice J. Neurosci., August 20, 2008; 28(34): 8624 - 8634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Laun, C. V. Bruschi, J. Richard Dickinson, M. Rinnerthaler, G. Heeren, R. Schwimbersky, R. Rid, and M. Breitenbach Yeast mother cell-specific ageing, genetic (in)stability, and the somatic mutation theory of ageing Nucleic Acids Res., December 11, 2007; (2007) gkm919v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Khan, R. M. Smigrodzki, and R. H. Swerdlow Cell and animal models of mtDNA biology: progress and prospects Am J Physiol Cell Physiol, February 1, 2007; 292(2): C658 - C669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S Parihar and G. J. Brewer Mitoenergetic failure in Alzheimer disease Am J Physiol Cell Physiol, January 1, 2007; 292(1): C8 - C23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Coskun, M. F. Beal, and D. C. Wallace Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication PNAS, July 20, 2004; 101(29): 10726 - 10731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Chabi, B. Mousson de Camaret, H. Duborjal, J.-P. Issartel, and G. Stepien Quantification of Mitochondrial DNA Deletion, Depletion, and Overreplication: Application to Diagnosis Clin. Chem., August 1, 2003; 49(8): 1309 - 1317. [Abstract] [Full Text] [PDF]
|
|